SCHEMBL9309717

SCHEMBL9309717

CCCCc1nc(Cl)c(CC(=O)OCC)n1Cc1ccc2oc(-c3ccccc3-c3nnn[nH]3)c(Br)c2c1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9694821 0.93 AGTR1 (0.55) AGTR1
SCHEMBL27348379 0.92 AGTR1 (0.64) AGTR1
SCHEMBL9309476 0.92 AGTR1 (0.64) AGTR1
SCHEMBL9311474 0.90 AGTR1 (0.60) AGTR1
SCHEMBL9309276 0.89 AGTR1 (0.68) AGTR1
SCHEMBL9308803 0.89 AGTR1 (0.61) AGTR1
SCHEMBL9309552 0.89 AGTR1 (0.62) AGTR1
SCHEMBL9694809 0.88 AGTR1 (0.61) AGTR1
SCHEMBL9308923 0.88 AGTR1 (0.58) AGTR1
SCHEMBL9859390 0.87 AGTR1 (0.62) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0434249-A2 Benzofuran derivatives GLAXO GROUP LIMITED (GB) 1991-06-26 EP claimed
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed